ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Direct Meds Celebrates 500% Growth at Inaugural Summit in San Diego, CA

Online telehealth provider specializing in weight loss medications celebrated 500% growth at its San Diego summit, introducing new tools to enhance patient access and support.

(PRUnderground) November 24th, 2025

Direct Meds is a fast-growing telehealth weight loss provider offering personalized care and fast access to GLP-1 medications, including semaglutide and tirzepatide. The company recently welcomed over 50 media partners, alongside vendors and team members from across the country at its company summit, held on November 6 – 7 at The Pendry Hotel in San Diego, California. The two-day event served as a platform for team-building, sharing strategies that have contributed to the company’s success, and unveiling new technology, all while celebrating the company’s remarkable 500% growth over the past year.

With more than 700 new patients joining daily and a 4.5 TrustPilot rating, Direct Meds is redefining how individuals access weight loss prescriptions online. The company helps patients begin and navigate safe, medically supervised weight loss journeys from the comfort of their own homes with the assistance of licensed providers and a growing tech-enabled infrastructure. The summit brought together key internal teams and external partners to reflect on that momentum and align around a vision for sustainable, scalable care.

“I had no idea the size of the operation and talent you guys have amassed behind the scenes. Amazing event!” remarked one media partner. This statement is a direct reflection of one reason why Direct Meds created the summit: to showcase the caliber of care and infrastructure that drives Direct Meds’ impact.

“Our growth is a reflection of the trust our patients place in us every single day,” said Dr. Justin Hohl, Direct Meds Medical Director. “The summit was a chance to honor that success and look forward to what’s next. Our patients want results, and they want them with minimal friction. That’s why we’ve doubled down on tools that simplify the care journey while keeping our providers and support teams closely connected to every individual.”

During the summit, Direct Meds unveiled many enhancements designed to improve the patient experience, but a new mobile app and an enhanced patient portal stole the show. These tools will provide patients with streamlined access to prescriptions, progress tracking, and medical support, all from the convenience of their smartphones. Their launch has the potential to accelerate engagement, compliance, and outcomes further.

While the weight loss medication space has become increasingly crowded, Direct Meds has emerged as a standout by focusing on:

  • Fast onboarding so patients receive medications and begin treatment quickly
  • Transparent pricing without hidden fees or markups
  • Access to licensed providers for patients
  • Scalable medication delivery with GLP-1 shipped to patients’ homes discreetly and securely

“Our mission is to combine expert medical care with the convenience patients want,” said Hohl. “We deliver GLP-1 medications quickly and discreetly, but just as importantly, we make sure every patient has access to knowledgeable providers who guide them through their treatment.”

To learn more about how Direct Meds streamlines access to GLP-1 medications through licensed providers and pharmacies or to schedule a consultation, call (888) 696-7176 or visit www.DirectMeds.com

About Direct Meds

Direct Meds transforms how healthcare is delivered by making prescription weight loss treatments more accessible. They believe that everyone deserves effective, reliable, and medically supervised solutions to manage weight and improve overall health.

The post Direct Meds Celebrates 500% Growth at Inaugural Summit in San Diego, CA first appeared on

Press Contact

Name: Direct Meds
Phone: 801-513-3736
Email: Contact Us

Original Press Release.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.